STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
Canada’s largest biotechnology company expands further into cancer diagnostic market with novel in vitro diagnostic medical device VANCOUVER, BC – STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone… Read More




